MyAverix Finance
F · Healthcare
AROVELLA THERAPEUTICS (E4NA)
Biotechnology
AROVELLA THERAPEUTICS (E4NA) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-03-28, reported market cap is $51.04M, P/E ratio is 18.00, net margin is -247.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for E4NA
AROVELLA THERAPEUTICS (E4NA) — FAQ
What is AROVELLA THERAPEUTICS's market cap?
AROVELLA THERAPEUTICS (E4NA) has a reported market cap of $51.04M (data as of 2026-03-28).
What is E4NA's P/E ratio?
The price-to-earnings (P/E) ratio for AROVELLA THERAPEUTICS (E4NA) is 18.00 (data as of 2026-03-28).
Does AROVELLA THERAPEUTICS pay a dividend?
Dividend yield is not available in the current snapshot for AROVELLA THERAPEUTICS (E4NA). Check the MyAverix Finance app for the latest dividend data.
What sector is AROVELLA THERAPEUTICS in?
AROVELLA THERAPEUTICS (E4NA) is classified in the Healthcare sector (Biotechnology industry).
What exchange is E4NA listed on?
E4NA is listed on F.
What is AROVELLA THERAPEUTICS's net margin?
AROVELLA THERAPEUTICS (E4NA) reports a net margin of -247.0% (data as of 2026-03-28).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.